This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Stock Market News for Nov 18, 2019
by Zacks Equity Research
Benchmarks closed at record highs on Friday on U.S.-China trade deal hopes in spite of mixed economic data.
UnitedHealth (UNH) Looks Good: Stock Adds 5.3% in Session
by Zacks Equity Research
UnitedHealth (UNH) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Healthcare Stocks in Focus on Price Transparency Rule
by Sapna Bagaria
Hospital stocks gain from a less-than-expected strict price transparency rule and health insurers' optimism on a likely rise in profitability from a low-cost plan.
US Equities Continue to March Steadily Higher
by David Borun
Positive developments in international trade and healthcare puch stocks to another round of new record highs.
UnitedHealth (UNH) Up 7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Mastercard, UnitedHealth, Merck, Qualcomm and CVS Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Mastercard, UnitedHealth, Merck, Qualcomm and CVS Health
More Record Highs in a Broadly Positive Week for US Equities
by David Borun
Easing of trade concerns and a steepening yield curve supporting steady share appreciation
Genesis Healthcare's (GEN) Q3 Earnings Beat, Improve Y/Y
by Zacks Equity Research
Genesis Healthcare's (GEN) third-quarter results reflect same store occupancy growth, partly offset by lower revenues.
Top Analyst Reports for Mastercard, UnitedHealth & Merck
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), UnitedHealth Group (UNH) and Merck (MRK).
Humana's (HUM) Q3 Earnings Surpass Estimates, Improve Y/Y
by Zacks Equity Research
Humana's (HUM) third-quarter results reflect higher revenues as well as solid membership growth.
DaVita (DVA) Earnings and Revenues Beat Estimates in Q3
by Zacks Equity Research
DaVita (DVA) raises guidance for 2019 following impressive Q3 results.
Tenet Healthcare (THC) Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter earnings gain from its Hospital and Other segment as well as volume growth.
MEDNAX (MD) Q3 Earnings In Line With Estimates, Decline Y/Y
by Zacks Equity Research
MEDNAX's (MD) results reflect escalating expenses in the third quarter.
Ensign Group's (ENSG) Q3 Earnings Miss Estimates, Rise Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) third-quarter earnings suffer escalating expenses.
Cigna (CI) Q3 Earnings & Revenues Beat Estimates, View Up
by Zacks Equity Research
Cigna (CI) Q3 results reflect higher revenues and membership from Express Scripts merger.
WellCare Health (WCG) Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
WellCare Health's (WCG) third-quarter results reflect improved revenues.
Community Health's (CYH) Q3 Loss Narrower Than Expected
by Zacks Equity Research
Community Health's (CYH) third-quarter results reflect decreased admissions.
Molina Healthcare (MOH) Q3 Earnings Surpass, Increase Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) third-quarter earnings benefit from lower expenses.
HCA Healthcare (HCA) Q3 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) third-quarter results gain traction from better revenues.
Universal Health's (UHS) Earnings Lag in Q3, Decline Y/Y
by Zacks Equity Research
Universal Health's (UHS) third-quarter results are hurt by high operating expenses.
The Zacks Analyst Blog Highlights: Facebook, UnitedHealth, HSBC, PetroChina and Netflix
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Facebook, UnitedHealth, HSBC, PetroChina and Netflix
Stocks Mostly Post Modest Gains During the First Week of Earnings Season
by David Borun
More than 80% of reporting companies beat estimates, but isolated bad news keeps a cap on the Dow
Top Analyst Reports for Facebook, UnitedHealth & HSBC
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), UnitedHealth (UNH) and HSBC Holdings (HSBC).
Tech Stocks for Dividend Investors to Buy as Q3 Earnings Season Heats Up
by Benjamin Rains
We used our Zacks Stock Screener to search for companies within the broader technology sector that also pay a dividend that investors might want to buy as Q3 earnings season heats up...
Healthcare ETFs to Buy on UnitedHealth's Solid Q3 Earnings
by Sweta Killa
Investors could tap the company's strong growth story with ETFs having the largest allocation to this health insurance giant.